If you're considering a medical weight program in midlife, the most valuable thing you can bring to that decision isn't a pros-and-cons list from the internet — it's a good set of questions for a real provider. The right questions surface whether a program is appropriate for you, whether the people running it are practicing careful medicine, and whether they understand the specific realities of a perimenopausal body. Here's a checklist worth bringing to any consultation, and why each item matters.
Questions about candidacy and safety
"Am I actually a good candidate — and how do you decide?" A responsible program doesn't treat everyone who asks as a yes. Standard candidacy for GLP-1 weight management generally starts around a BMI of 30, or 27 with a weight-related condition — but candidacy is about more than a number. It's about your full metabolic picture, your history, and how that changes the risk-benefit balance. A provider who can explain their criteria is practicing medicine; one who approves everyone isn't.
"What in my history would make this inappropriate?" There are real contraindications — a personal or family history of medullary thyroid carcinoma or MEN2 syndrome, certain gastrointestinal conditions, prior pancreatitis, among others. You want a provider who screens for these actively, not one who waits for you to volunteer them. (We cover what a genuine evaluation looks like in our article on provider-reviewed care.)
"What are the side effects, and what's the plan when they happen?" Gastrointestinal effects like nausea are common, especially around dose changes. The tell of a careful program is a concrete plan — a stepwise approach to managing side effects and a titration schedule that starts low and adjusts gradually — rather than vague reassurance.
The questions specific to a perimenopausal body
This is where midlife women should push, because these considerations are real and under-discussed in typical weight-loss marketing.
"How will we protect my muscle?" This is the big one. Weight loss from any method includes some loss of lean muscle mass — and in midlife, that lands on top of the muscle loss that already comes with declining estrogen and age. Muscle is metabolically precious: it's what keeps resting metabolism up and mobility intact. A provider who takes midlife seriously will make muscle protection — resistance training, adequate protein — a central part of the plan, not an afterthought. If muscle never comes up, that's a gap. (Our articles on perimenopausal metabolism cover why this matters so much.)
"What about bone density?" Perimenopause is already a period of accelerating bone loss as estrogen declines. Rapid weight loss can affect bone, so it's a reasonable thing to ask how a program accounts for it in a woman already in that window. You don't need a definitive answer — you need a provider who takes the question seriously rather than waving it off.
"How will we tell what's driving changes?" In midlife, a stall or a symptom can be dose-related, muscle-related, sleep-related, or hormone-related — the variables tangle together. A good provider will have a way of thinking through which is which, rather than defaulting to "just increase the dose."
"How do sleep, stress, and hormonal changes factor in?" Perimenopausal sleep disruption can drive hunger and affect blood-sugar control directly. A program that ignores the hormonal-transition context is treating a midlife body as if it were a younger one.
Questions about the medication itself
"Is this compounded or FDA-approved — and are you clear about the difference?" This matters. Compounded semaglutide and tirzepatide are not FDA-approved — the branded versions are approved for their indications, but compounded products, while containing the same active ingredient, have not undergone the FDA's review for safety and efficacy. A trustworthy provider is transparent about this distinction rather than blurring it. (We explain it fully in our article on compounded vs. brand GLP-1.)
"What's the ongoing care, not just the prescription?" Prescribing is the start of care. Ask about follow-up cadence, how dose adjustments are handled, and how you'll reach someone if something goes wrong.
Questions about the business, not just the medicine
"Who is the prescriber, and what are their credentials?" You should be able to know a licensed clinician is reviewing your care.
"Is there a contract or lock-in?" Long minimum commitments serve the business, not your health. So do high-pressure tactics — countdown timers, "spots filling up." Those are marketing, not medicine, and their presence tells you something.
"What happens if I stop?" A straight answer about what discontinuation looks like is a sign of a provider treating you as a patient rather than a subscription.
The underlying principle
Notice what all these questions have in common: they assume you're entitled to a real clinical relationship, honest information, and a plan built around your actual body. That's not a high bar — it's the baseline. A provider who welcomes these questions is showing you how they practice. One who deflects them is also telling you something.
Where care fits
Bringing good questions to the table is how you find care worth trusting. Cypress is built to answer exactly these: a licensed provider reviews your history and goals, screens for what matters, is transparent about what you're getting, and designs care for the perimenopausal body specifically. If you want to see what that review involves, you can learn how provider-reviewed care works.